Loading...
Loading...
Merck & Co Inc.
MRK, is reportedly in talks to acquire Lexington, MA-based Cubist Pharmaceuticals Inc.
CBST for around $7.5 billion, or approximately $100 per share according to the
NY Times DealBook. A deal could be announced as early as next week, according to persons familiar with the matter.
Cubist shares closed Friday at $74.36, down $0.16.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in